Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.95 SEK
−272.51 M SEK
16.16 M SEK
About IMPLANTICA AG SDB
Sector
Industry
CEO
Peter Forsell
Website
Headquarters
Vaduz
Founded
2015
ISIN
SE0014855029
FIGI
BBG00X26KVL7
Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.